Related Experiment Video
Updated: Feb 26, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.4K
Intravascular large B-cell lymphoma presenting clinically as rapidly progressive dementia
F M Brett1,2, D Chen3, T Loftus3
1Department of Clinical Neurological Sciences, RCSI, Dublin 9, Ireland. francescabrett@rcsi.ie.
Irish Journal of Medical Science
|July 21, 2017
Summary
Intravascular large B-cell lymphoma can mimic prion disease in patients with rapidly progressive dementia. Early diagnosis via brain biopsy is crucial, as this rare cancer is often mistaken for Creutzfeldt-Jakob disease (CJD).
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Prion diseases are a key differential diagnosis for rapidly progressive dementia.
- Primary CNS lymphoma and intravascular large B-cell lymphoma are rare malignancies that can mimic prion disease.
- Diagnosis often requires invasive procedures like brain biopsy due to overlapping clinical presentations.
Observation:
- An 82-year-old female with hypertension presented with rapidly progressive cognitive impairment and ataxia.
- Creutzfeldt-Jakob disease (sCJD) was initially suspected.
- Brain biopsy revealed intravascular large B-cell lymphoma, with negative prion protein Western blot.
Findings:
- Intravascular large B-cell lymphoma can present with diverse neurological symptoms, including dementia, seizures, and myoclonus.
- The clinical presentation can lead to a misdiagnosis of sCJD.
- Diagnosis was confirmed by biopsy in this case, but is often made post-mortem.
Implications:
- Highlights the importance of considering intravascular large B-cell lymphoma in the differential diagnosis of rapidly progressive dementia.
- Emphasizes the diagnostic challenges and the potential for misdiagnosis without definitive tissue analysis.
- Underscores the need for prompt diagnostic evaluation, as delays can impact patient outcomes.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Dementia
605
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
605
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
Primary Lymphoid Organs
16.2K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.2K

